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Their precursor is ceramide, which is made in the ER and delivered 
to the Golgi by a combination of CERT and vesicular traffi  c. 
Almost all other enzymes involved in glycolipid metabolism are 
in the Golgi complex, adding sugars step-wise to generate many 
hundreds of complex glycolipids (Fig. 1 A). Importantly, the 
fi  rst enzyme, GlcCer synthase, has its active site on the cyto-
plasmic leafl  et, whereas all of the others have active sites on the 
lumenal leafl  et (Fig. 1 B).
D’Angelo et al. (2007) and Halter et al. (2007) both fi  nd 
that decreasing FAPP2 levels by RNA interference reduces the 
conversion of GlcCer to lactosylceramide (LacCer) and down-
stream glycolipids. D’Angelo et al. (2007) also show that 
FAPP2 has GlcCer transfer activity in vitro. The implication of 
this shared fi  nding is surprising. Why would GlcCer need to traffi  c 
away from the Golgi if it is both synthesized and consumed 
there? Maybe the assignments of where the enzymes are localized 
are wrong, as these were made before the genes were cloned. 
To address this, Halter et al. (2007) revisit the localization of three 
enzymes at the start of the pathway. All three synthases are en-
riched in the latter half of Golgi stacks, overlapping extensively 
(Fig. 1 B), so the role of FAPP2 is not explained by physical 
separation of the enzymes.
At this point, Halter et al. (2007) reevaluate another long-
held notion that an ABC pump in the Golgi translocates GlcCer 
from the cytoplasmic to the lumenal leafl  et. Certainly, a GlcCer 
analogue with the long acyl chain replaced by a more hydro-
philic fl  uorescent group does fl  ip by this means, but Halter et al. 
(2007) now fi  nd that endogenous, fully hydrophobic GlcCer 
does not fl  ip at all in the Golgi or by ABC pumps. The rest of 
their study examines the journey of a few nanometers by which 
GlcCer moves from one leafl  et of the Golgi to the other, dis-
covering two new sites of GlcCer fl  ipping (Fig. 1 C).
One pathway is revealed by collapsing the Golgi into the 
ER using brefeldin A (BFA). This stimulates GlcCer fl  ipping 
considerably, presumably because it can access the nonspecifi  c 
ER lipid fl  ippase (Menon et al., 2000). To test the in vivo rel-
evance of this pathway, Halter et al. (2007) identify GlcCer that 
traffi  cs back to the ER lumen by expressing the enzyme that 
normally adds sulfate to galactosylceramide (but also acts on 
GlcCer) fused to the transporter of the sulfate donor. Although both 
of these enzymes are normally found in the TGN, fortuitously, 
the chimera never leaves the ER, so the formation of sulfated 
GlcCer can be used to indicate retrograde traffi  c. This is largely 
(>80%) blocked by the knockdown of FAPP2, which must 
mediate the retrograde traffi  c of GlcCer to the ER, although the 
volume of GlcCer passing through the ER is not assessed.
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Very few lipid transfer proteins (LTPs) have been caught 
in the act of transferring lipids in vivo from a donor mem-
brane to an acceptor membrane. Now, two studies (Halter, 
D., S. Neumann, S.M. van Dijk, J. Wolthoorn, A.M. de 
Maziere, O.V. Vieira, P. Mattjus, J. Klumperman, G. van 
Meer, and H. Sprong. 2007. J. Cell Biol. 179:101–
115; D’Angelo, G., E. Polishchuk, G.D. Tullio, M. Santoro, 
A.D. Campli, A. Godi, G. West, J. Bielawski, C.C. Chuang, 
A.C. van der Spoel, et al. 2007. Nature. 449:62–67) 
agree that four-phosphate adaptor protein 2 (FAPP2) 
transfers glucosylceramide (GlcCer), a lipid that takes an 
unexpectedly circuitous route.
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Lipids are made by membrane-embedded synthases, and then 
they move in the secretory pathway by en bloc inclusion in 
membrane vesicles and by two additional mechanisms unique 
to lipid traffi  c. First, they translocate (fl  ip) between the two 
leafl  ets of lipid bilayers. For lipids with hydrophilic headgroups, 
the bilayer presents a strong diffusion barrier, and this traffi  c is 
mediated by fl  ippases or pumps. Because lipid synthases have 
their active sites on one side of the membrane only, the two 
leafl  ets of most lipid bilayers in vivo are asymmetric. Second, 
LTPs bind lipids in a hydrophobic pocket and carry them across 
the aqueous environment of the cytoplasm. LTPs were all 
originally identifi  ed from in vitro activities, and it has been hard 
to generate strong evidence for lipid transfer in living cells. 
A benchmark was recently set by the ceramide transporter 
(CERT), which shuttles ceramide between the ER and TGN 
(Hanada et al., 2007). Now, two new studies show that FAPP2 
is also an authentic LTP (see Halter et al. on p. 101 of this 
issue; D’Angelo et al., 2007).
Lipid transfer by FAPP2 has not been studied previously, 
but it contains a domain that is also found in glycolipid transfer 
protein (GLTP), which transfers simple glycolipids in vitro 
(Brown and Mattjus, 2007). FAPP2 had been shown to con-
tribute to an aspect of membrane traffi  c from the TGN to the 
plasma membrane (Godi et al., 2004), but the precise roles of 
both FAPP2 and GLTP are unclear, possibly because there is 
no apparent need for the cytoplasmic transfer of glycolipids. JCB • VOLUME 179 • NUMBER 1 • 2007  12
Halter et al. (2007) discover yet another pathway of 
GlcCer traffic that contributes to its arrival on the cell sur-
face. The majority of this is abolished by BFA, but 30% is 
resistant to BFA, and this needs vacuolar ATPase function, 
suggesting that translocation occurs in an acidic compart-
ment, possibly early endosomes, which continue to function 
in the presence of BFA. How GlcCer arrives here is unclear, 
and it does not appear to need transfer by FAPP2, although 
the model favored by D’Angelo et al. (2007) is most consis-
tent with this second pathway. This is one of many details 
that remain to be explained for the work of the two groups to 
be unified.
What might be the advantage for cells to take ceramide 
from the ER to the Golgi to make GlcCer, just to transfer it back 
to the ER? The detour is not essential, as fl  ies avoid it by placing 
GlcCer synthase in the ER (Kohyama-Koganeya et al., 2004), 
and they also do not have a FAPP homologue. One possible 
advantage is that FAPP2 is one step in glycolipid metabolism 
that can be regulated easily. FAPP2 targets Golgi membranes by 
its pleckstrin homology (PH) domain, which binds both Arf1 
and the signaling lipid phosphatidylinositol 4-phosphate (PI4P; 
Godi et al., 2004). It is known that the production of PI4P is 
essential for TGN exit in all eukaryotes, and mammalian cells 
have at least two different PI 4-kinases on the Golgi. D’Angelo 
et al. (2007) focus on this point and show that the function of 
FAPP2 in post-TGN traffi  c not only requires it to bind glycolipids 
but also depends on its PH domain binding PI4P. Therefore, this 
key molecule regulates glycolipid synthesis, among other aspects 
of Golgi function.
These studies confi  rm that LTPs do sometimes transfer 
lipids rather than merely sensing them. CERT has been the model 
LTP for a hypothesis that dual targeting to donor and acceptor 
is key for lipid transfer at membrane contact sites (Fig. 1 B; 
Olkkonen and Levine, 2004). In addition to its PH domain like 
FAPP2, CERT contains a domain targeting it specifi  cally to the 
ER, without which it cannot acquire ceramide effi  ciently (Hanada 
et al., 2007). Can FAPP2 effi  ciently deliver GlcCer to the ER 
without specifi  c ER targeting, or does FAPP2 target the ER by 
a mechanism we have yet to discover? It is even possible that 
PH FAPP2 carries out this function because the portion of ER 
within the Golgi region (Fig. 1 B) is highly enriched for PI4KIIα 
(Waugh et al., 2003), and D’Angelo et al. (2007) fi  nd that this 
PI 4-kinase makes the majority of PI4P that recruits FAPP2. 
One way or another, studies of GlcCer transfer by FAPP2 will 
force a reevaluation of still more ideas in the future.
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Figure 1.  Pathways of glycolipid trafﬁ  c. (A) Ceramide is synthesized 
and converted into a large array of glycolipids by an ordered series of 
enzymatic steps. (B) Localization of ceramide synthase (1) is in the ER; 
Halter et al. (2007) ﬁ  nd synthases for GlcCer (2), LacCer (3), and GM3 
(4) overlap in the trans-Golgi (and presumably TGN). Lipid trafﬁ  c is medi-
ated by vesicular trafﬁ  c (black arrows) and also by LTPs and ﬂ  ippases. 
A nonspeciﬁ  c ﬂ  ippase equilibrates the leaﬂ  ets of the ER, but the two leaﬂ  ets 
of post-ER membranes are highly asymmetric. A portion of ER interdigi-
tates among trans-Golgi/TGN membranes, making ER-Golgi contacts 
(asterisks) ideal sites for LTP function. (C) Several other proteins are in-
volved in these pathways. CERT is critical for the transfer of ceramide from 
the ER to the cytoplasmic leaﬂ  et of the TGN for sphingomyelin (SM) synthe-
sis, but the role of CERT in GlcCer synthesis is unclear. GlcCer translocates 
from the cytoplasmic to the lumenal leaﬂ  et, but not (as once thought) using 
an ABC pump. Instead, GlcCer trafﬁ  cs away from its site of synthesis, either 
transferred by FAPP2 back to the ER or another route, possibly via early 
endosomes (EE). GlcCer returns to the Golgi/TGN in the lumenal leaf-
let for conversion to LacCer and other glycolipids. Note that ceramide 
ﬂ  ips easily in post-ER membranes, as it has no polar headgroup. Black 
arrows indicate enzymatic conversion or vesicular trafﬁ  c; colored arrows 
indicate lipid trafﬁ  c steps. Cer, ceramide; GlcC, glucosylceramide; LacC, 
lactosylceramide; GalC, galactosylceramide. Color-coded localizations: ER 
(both leaﬂ  ets), green; post-ER, blue and orange (lumenal and cytoplasmic 
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